Free Trial

FOXO Technologies Q1 2023 Earnings Report

FOXO Technologies logo
$0.28 -0.01 (-4.42%)
(As of 12/20/2024 05:31 PM ET)

FOXO Technologies EPS Results

Actual EPS
-$3.30
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

FOXO Technologies Revenue Results

Actual Revenue
$0.01 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

FOXO Technologies Announcement Details

Quarter
Q1 2023
Time
N/A

Conference Call Resources

Your bank is lying to you. (Ad)

You might think you have your money in a high-yield savings account, but do you really? The national average APY on savings is just 0.58%, but you can get up to 5.0% APY online with these accounts.

View the best savings account rates here

FOXO Technologies Earnings Headlines

FOXO Technologies regains NYSE compliance, ends indicator
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
FOXO Technologies Regains NYSE Compliance with Equity Boost
FOXO Technologies Strengthens Financials and Leadership
See More FOXO Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like FOXO Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on FOXO Technologies and other key companies, straight to your email.

About FOXO Technologies

FOXO Technologies (NYSEAMERICAN:FOXO) engages in epigenetic biomarker underwriting technology and consumer engagement platform service business in the United States. It operates through two segments, FOXO Labs and FOXO Life. The company applies automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers of human health, wellness, and aging. It offers FOXO Labs, a commercializing proprietary epigenetic biomarker technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and FOXO Life, a sales and distribution platform focused on recruiting independent life insurance agents to sell life insurance with the Longevity Report. The company was founded in 2020 and is based in Minneapolis, Minnesota. FOXO Technologies Inc. is a subsidiary of FOXO Management LLC.

View FOXO Technologies Profile

More Earnings Resources from MarketBeat

Upcoming Earnings